Skip to content

Advertisement

  • Poster presentation
  • Open Access

Socio psychiatric aspects of risperiodone

  • 1,
  • 2,
  • 2,
  • 2 and
  • 2
Annals of General Psychiatry20065 (Suppl 1) :S204

https://doi.org/10.1186/1744-859X-5-S1-S204

  • Published:

Keywords

  • Public Health
  • Mental Health
  • Schizophrenia
  • Psychotic Symptom
  • Community Mental Health

Background

Resocialisation process and techniques are the key point of interdependance of social psychiatry and psychopharmacology. Risperidon as a neuroleptic of new generation has shown more qulitative improvement in the extra hospital conditions than in conditions in hospital treatement.

Materials and methods

It was examined two groups of patients. The first group was from the 20 users in Community mental health, with diagnosis of schizophrenia and the second one was from the 20 patients, admited with diagnosis of schizophrenia in Mental hospital. On the two groups were applied PANSS and CGI quertionarie.

Results

In the first group, results were: more quickly reduction of the psychotic symptoms, application of low doses of Risperidon (1.5–3 mg per day), much more qualiative remission. Also, it was not necessary to apply another neuroleptics.

Discussion

A combination of new neuroleptics (Risperidon) and resocialisation techniques and process, esspeccilay in the extra hospital condition, is the treatment of choise in the present stage of knowledge. It helps a rational administration of psychotropics and use up patients vital existential potentialites.

Authors’ Affiliations

(1)
Community Mental Health Prilep, F.Y.R.O.M
(2)
Mental Hospital Demir Hisar, F.Y.R.O.M

References

  1. Cadlovski G: Clinical Psychopharmacology. 2003Google Scholar
  2. Kaplan H, Sadock B: Comprehensive Textbook of Psychiatry. 1998, ThirdGoogle Scholar
  3. Hogarty GE, Anderson CM, Reiss DJ: Family psychoeducation, social skills training and maintenance therapy in the aftercare treatment of schizophrenia. Arch Gen Psychiatry. 1991, 48: 340-347.View ArticlePubMedGoogle Scholar
  4. Peuskens J, Risperidone Study Group: Br J Psychiatry. 1995, 166: 712-726.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2006

Advertisement